Context

Leishmaniasis is considered to be one of the most serious parasitic infections affecting humans worldwide and represents a major public health concern in Latin America, Asia, Africa, and southern Europe.

Benefits

The team identified a cocktail of multi-epitope peptides that activate the immune system specifically to fight different species of Leishmania.

Applications

This project seeks to develop a new prophylactic vaccine solution against leishmaniasis to provide optimal vaccination coverage for the population, notably in southern countries and countries developing as a result of migration and military flows.